Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. [electronic resource]
Producer: 20140522Description: 772-80 p. digitalISSN:- 1399-0012
- Adult
- Aged
- Alemtuzumab
- Allografts
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antilymphocyte Serum -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Case-Control Studies
- Delayed Graft Function -- diagnosis
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Graft Rejection -- diagnosis
- Humans
- Immunosuppressive Agents -- therapeutic use
- Inflammation -- diagnosis
- Kidney Failure, Chronic -- complications
- Kidney Function Tests
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Mycophenolic Acid -- analogs & derivatives
- Prognosis
- Risk Factors
- T-Lymphocytes -- immunology
- Tacrolimus -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.